drugset / Trial / NCT02084420

Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment

NCT02084420

Phase 3 Completed 323 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate of efficacy and safety as H.pylori eradiation effect between Ilaprazole and Pantoprazole triple therapy for 7 days treatment in Gastric and/or Duodenal ulcer patients with H.pylori positive infection.

Timeline

Start
2012-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ilaprazole Small molecule 10 mg Oral
Comparator Pantoprazole Other / unclassified 40 mg Oral

Indications